175 Chronic oral ET-A receptor antagonism in experimental heart failure activates the renin-angiotensin system resulting in persistent sodium retention

Schirger, J.; Chen, H.H.; Burnett Jr., J.C.
June 2004
European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p34
Academic Journal
An abstract of the article "Chronic Oral ET-A Receptor Antagonism in Experimental Heart Failure Activates the Renin-Angiotensin System Resulting in Persistent Sodium Retention," by J. Schirger and colleagues is presented.


Related Articles

  • 597 Association between the renin-angiotensin-aldosterone system gene polymorphism and heart failure of ischemic aetiology.  // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p135 

    An abstract of the study "Association Between the Renin-Angiotensin-Aldosterone System Gene Polymorphism and Heart Failure of Ischemic Aetiology," by M. Mendonca and colleagues, is presented.

  • Acute intermittent hypoxia evokes sympathetic long-term facilitation (LTF) via activation of the renin-angiotensin system (RAS). Fong, A. Y.; Hammond, A. M.; Xing, T.; Pilowsky, P. M. // Proceedings of the Physiological Society;2014, p60P 

    An abstract of the article "Acute intermittent hypoxia evokes sympathetic long-term facilitation (LTF) via activation of the renin-angiotensin system (RAS)" by A. Y. Fong, A. M. Hammond, T. Xing and P. M. Pilowsky is presented.

  • Role of aldosterone blockade in managing heart failure: New and emerging treatment options.  // American Journal of Health-System Pharmacy;5/1/2004 Supplement 2, Vol. 61, p23 

    Focuses on the role of aldosterone blockade in managing heart failure. Social and economic impact of heart failure in the U.S.; Role of neurohormonal mediators in renin-angiotensin-aldosterone and sympathetic nervous system in heart failure.

  • The ELITE Study: What are its Implications for the Drug Treatment of Heart Failure? Aronow, W.S. // Drugs & Aging;1998, Vol. 12 Issue 6, p423 

    Angiotensin II type 1 (AT) receptor antagonists inhibit the renin-angiotensin system more completely than ACE inhibitors, and do not increase bradykinin levels as ACE inhibitors do. ACE inhibitors have been proven to increase survival and improve quality of life in patients with congestive heart...

  • The increasing applications of AIIRAs. Morris, David // GP: General Practitioner;6/30/2003, p34 

    Like ACE inhibitors, angiotensin II receptor antagonists (AIIRAs) target the renin-angiotensinaldosterone system, although they act at a different site in the pathway. AIIRAs are licensed for hypertension, but as evidence accumulates they are finding increasing use in the treatment of cardiac...

  • Therapeutic Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure. Monohar, Prerana; Pina, Ileana L. // Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p334 

    Examines the effects of angiotensin II receptor blockers (ARB) on the treatment of heart failure. Renin-angiotensin system; Characteristics of ARB; Evaluation of Losartan in the elderly trial; Evaluation of strategies for left ventricular dysfunction.

  • Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure. Fonarow, Gregg C.; Ahmed, Ali; Lund, Lars H.; Benson, Lina // JAMA: Journal of the American Medical Association;3/20/2013, Vol. 309 Issue 11, p1107 

    A letter to the editor is presented focusing on the use of renin-angiotensin system (RAS) antagonists and mortality in patients with heart failure with preserved ejection fraction (HFPEF) as reported by researcher L. H. Lund and his colleagues.

  • The renin-angiotensin system: new concepts and perspectives. Santos, R. A. // Proceedings of the Physiological Society;2013, p11P 

    Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil It is well known that the renin-angiotensin system (RAS) is a key regulator of the cardiovascular system and the hydro-electrolyte balance. The classical concept of the RAS in which the...

  • The Importance of Lost Minerals in Heart Failure. Newman, Kevin P.; Neal, Matthew T.; Roberts, Matthew; Goodwin, Kayla D.; Hatcher, Elizabeth A.; Bhattacharya, Syamal K. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2007, Vol. 5 Issue 4, p295 

    The clinical syndrome congestive heart failure (CHF) has its origins rooted in a salt-avid state mediated largely by effector hormones of the renin-angiotensin-aldosterone system (RAAS). In addition, a systemic illness accompanies chronic RAAS activation. Its features include: the presence of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics